<?xml version="1.0" encoding="UTF-8"?>
<p>It has been documented that the brain cells express ACE2 receptors that were observed over glial cells and neurons, making them a possible target for SARS‐CoV‐2 (Zhao et al., 
 <xref rid="and13712-bib-0062" ref-type="ref">2016</xref>; Zhou et al., 
 <xref rid="and13712-bib-0063" ref-type="ref">2020</xref>). A recent study showed that the SARS‐CoV‐2 genomic sequence is similar to the previous SARS‐CoV virus (Yu, 
 <xref rid="and13712-bib-0061" ref-type="ref">2020</xref>), particularly the SARS‐CoV receptor‐binding domains being structurally identical to that of the SARS‐CoV‐2 (Lu et al., 
 <xref rid="and13712-bib-0028" ref-type="ref">2020</xref>). It suggests that SARS‐CoV and SARS‐CoV‐2 share the receptor ACE2, which could be the reason why SARS‐CoV and SARS‐CoV‐2 could invade the same location in the human brain. Previous experiments have shown SARS‐CoV's capacity to induce neuronal death in mice by entering the brain through the nose around the olfactory epithelium (Hamming et al., 
 <xref rid="and13712-bib-0018" ref-type="ref">2004</xref>; Netland, Meyerholz, Moore, Cassell, &amp; Perlman, 
 <xref rid="and13712-bib-0034" ref-type="ref">2008</xref>). The neurological damage was also observed in the SARS‐CoV and MERS‐CoV infections (Arabi et al., 
 <xref rid="and13712-bib-0002" ref-type="ref">2017</xref>; Desforges et al., 
 <xref rid="and13712-bib-0012" ref-type="ref">2019</xref>).
</p>
